<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Gaurav Kumar received primary medical education and core oncology training from India. After working as a consultant in oncology in India for many years he attained the Certificate of Equivalence for Specialist Registration (CESR) from the General Medical Council (GMC) in 2015. Since then he has been working as a Consultant Clinical Oncologist at The James Cook University Hospital, Middlesbrough. Dr. Kumar also has peripheral clinics at North Tees and Hartlepool Hospitals NHS Foundation Trust.</p> <p>With a special interest in lung and urological cancers including prostate and bladder cancer, he has vast experience in treating these conditions with radiotherapy, chemotherapy and immunotherapy. Besides this he has interests in targeted therapies like Stereotactic Ablative Radiotherapy (SABR/SBRT). With a key interest in clinical trials he has been a part of many national and international trials in both thoracic and urological malignancies. He has been involved in many national and international peer reviewed research article publications from time to time.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>He combines being the Director of the Bellmunt Oncology Institute at the Hospital Universitari Dexeus &middot; Grupo Quir&oacute;nsalud with being the Director of the Bladder Cancer Clinic of the Dana Farber Cancer Institute of Harvard in Boston (USA).</p> <p>He is an Associate Professor at Harvard. His areas of interest in research are Genito-Urinary clinical oncology, drugs focused on new therapeutic targets and early and transitional clinical research in the area of growth factor receptors and angiogenesis, among others, as the targets of cancer therapy. He is a member of the American Society for Cancer Research, of the American Clinical Oncology Association, of the European Medical Oncology Association and of the Spanish Medical Oncology Association.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Krishnamurthy Sairam is a consultant urologist with over 20 years of clinical experience. He conducted much of his training in the UK including his higher surgical training in Urology which he undertook at the London Deanery. In addition to his work experience in the UK, he was also Urology Tutor and Course Director of Laparoscopy in Urology at the Ethicon Institute of Surgical Education in India from 2012 to 2014 and served as faculty in the Board of Education, Urological Society of India.</p> <p>Dr. <span style="text-align: justify;">Sairam</span> has published extensively, including peer reviewed articles, abstracts, book chapters and editorials. He has also done several regional, national and international presentations.</p> <p><strong>His core competencies are:</strong></p> <ul> <li>Urological cancers, particularly prostate, bladder, kidney, testis&nbsp;</li> <li>BPH, OAB, erectile dysfunction&nbsp;</li> <li>Laparoscopic surgery - nephrectomy, cystectomy, pyeloplasty, adrenalectomy, varicocelectomy&nbsp;</li> <li>Ureteroscopy and laser surgery for stones, ESWL (lithotripsy)&nbsp;</li> <li>TURP, TURBT, Holmium &amp; Greenlight laser prostatectomy</li> </ul> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Mudhar is a consultant urologist with over 15 years&#39; experience. He worked at Danderyd University Hospital and Karolinska Institute, Stockholm, Sweden for the last eight years. Dr. Mudhar graduated from the College of Medicine at Baghdad University and completed his urological training at Karolinska University Hospital in Stockholm 2010 and was the Head of the Department of Urology at Danderyd Hospital and Karolinska Institutet between 2012 and 2017.</p> <p>Dr. Mudhar is a well experienced endourologist and robotic surgeon dealing with renal stones, bladder tumours and upper urinary tract tumors together with prostate cancer. Dr Mudhar has done more than 350 robotic procedures.</p> <p><strong>His core competencies are:&nbsp;</strong></p> <ul> <li>Robotic urological procedures</li> <li>Prostate cancer</li> <li>Bladder cancer</li> <li>Renal stones</li> <li>Tumours of the upper urinary tract</li> <li>Urinary incontinence in women</li> </ul> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Honored with the prestigious Padma Shri Award, Dr. Ashok Vaid has the unique distinction of carrying out the first 25 bone marrow transplants in any private sector hospital in North India. He has also conducted more than 40 international and national studies in clinical research and is known for organizing numerous seminars, workshops and conferences.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Miguel &Aacute;ngel L&oacute;pez Costea is a renowned surgeon specialized in the treatment of urological cancers using the Da Vinci system.&nbsp;<span style="text-align: justify;">He is also the Organizer and Professor of the Experimental and Clinical Laparoscopic Surgery course, which takes place biannually at the Animal Facility of the University of Barcelona and Bellvitge University Hospital ​(2005 - present).&nbsp;</span>He is currently Head of the Urology Unit at Quri&oacute;nsalud Barcelona Hospital. His team performs different laparoscopic and endoscopic surgical techniques, which enables them to resolve a large number of oncological and restorative processes, such as prostate cancer, kidney cancer, bladder cancer, urolithiasis (stones) or urinary tract malformations. Furthermore, the team performs minimally invasive surgery to be able to treat previously inoperable patients.</p> <p><span style="text-align: justify;">Dr.&nbsp;Miguel &Aacute;ngel L&oacute;pez Costea&nbsp;is also the author of numerous scientific publications and articles as well as books.&nbsp;</span>He<span style="text-align: justify;">&nbsp;is also the a</span>uthor and co-author of 130 presentations and papers to national and international congresses <span style="text-align: justify;">and&nbsp;</span><span style="text-align: justify;">various textbook chapters on the speciality as well as </span>published <span style="text-align: justify;">37 articles&nbsp;</span>in national and international specialised journals.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr Jason Lester is a senior Consultant Clinical Oncologist based in South Wales. He trained and qualified in United Medical and Dental Schools of Guy&rsquo;s &amp; St Thomas&rsquo;s in 1993. He completed his general medical training in London and the South East of England before moving to Wales in 1997. He joined Velindre Cancer Centre in 1997 and completed his Clinical Oncology training in 2003.</p> <p>Dr Lester was appointed as a consultant Oncologist in 2003, specialising in the management of lung (non-small cell, small cell, mesothelioma) and urological (prostate, kidney, bladder) cancers. His NHS practice is based in South East Wales, with clinics in The Royal Gwent Hospital Newport, University Hospital Llandough, Cardiff and Velindre Cancer Centre, Cardiff. He is an Associate Clinical Director at Velindre and Director of Stepping Stones, the Wales-based lung cancer charity.</p> <p>He is currently Deputy Clinical Director of Velindre Cancer Centre, and Chairman of the Rutherford Cancer Centre Local Medical Advisory Committee for Wales. He is also the Clinical Lead for the All Wales Prostate Cancer Brachytherapy Service.</p> <p>Dr Lester participates in a large number of clinical trials in both lung and urological cancer sites, and has published extensively in these fields. He is the lead investigator in the I-START trial, (dose escalated radiotherapy) and the SKOPOS trial, a vaccine trial in malignant pleural mesothelioma. He is responsible for prescribing and supervising the administration of radiotherapy, radioisotope treatment, cytotoxic chemotherapy and hormone therapy.</p> Read More

<script type="application/ld+json"> {"@context":"https://schema.org/", "@type":"Physician", "name":"Craig G Rogers", "url":"https://myacare.com/doctor/dr-craig-g-rogers-united-states", "description":"Dr. Rogers specializes in robotic surgery for kidney cancer, prostate cancer, adrenal tumors, testis cancer, penile cancer and bladder cancer. He also performs robotic surgery for blockages of the ureter, including robotic pyeloplasty for ureteropelvic junction obstruction and robotic ureteroplasty or ureteral reimplant for ureteral strictures.", "medicalSpecialty":["Kidney Cancer Specialist","Prostate Cancer Specialist","Oncologist","Specialist in robotic pyeloplasty for ureteropelvic junction obstruction","Specialist in robotic ureteroplasty"], "memberOf":[{ "@type":"MedicalClinic","name":"Henry Ford Hospital", "url":"https://myacare.com/healthcare-provider/henry-ford-hospital-united-states" }] },] </script> <style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>I specialize in robotic surgery for kidney cancer, prostate cancer, adrenal tumors, testis cancer, penile cancer and bladder cancer. I also perform robotic surgery for blockages of the ureter, including robotic pyeloplasty for ureteropelvic junction obstruction and robotic ureteroplasty or ureteral reimplant for ureteral strictures.</p> <p><strong>Care Philosophy:</strong></p> <p>I strive to provide exceptional care to all of my patients efficiently, effectively, and compassionately. I feel that the patient should always come first. I provide my patients with accurate information about their condition to help them make goals.</p> <p><strong>Biographical Statement:</strong></p> <p>Dr. Rogers has trained at some of the top medical centers in the country and has learned alongside the pioneers of these techniques. He attended Stanford University School of Medicine and received his M.D. degree. He completed his urology residency at the Johns Hopkins Hospital followed by a urologic oncology fellowship in prostate and kidney cancer surgery at the National Cancer Institute.</p> <p>Dr. Rogers performs both robotic and laparoscopic surgery to remove kidney tumors. Whenever possible, he uses robotic assistance to remove the tumor while saving the rest of the normal kidney in order to preserve kidney function. He also performs open surgery for kidney tumors that are not amenable to a minimally invasive approach. He also offers cryoablation for small kidney tumors in patients who are not candidates for surgical removal.</p> <p><strong>Research Interests:</strong></p> <p>His research focus is on improving robotic surgical techniques for kidney cancer and the identification and utilization of biomarkers and genes for the diagnosis, prognosis and treatment of kidney and prostate cancer.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Fadi has been working in the field of Medical Oncology and Hematology for many years in several hospitals and departments in Ukraine, France and the UAE. He has been given the title Ancient Interne des Hopitaux de Paris, after being trained in most leading cancer centers in France.</p> <p>Dr. Fadi Mikhael was born in Lebanon and graduated from College des Fr&egrave;res, a French school in 1987. He achieved the MBBS qualification in France in 1997 and pursued specialization in Medical Oncology and Hematology at the National Cancer Centre of France. In 1999 he joined the French University Rene Descartes- Paris V and completed the Fellowship program in Medical Oncology and has been granted the Diploma in Medical Oncology from University Rene Descartes. In 2008 after specializing in Palliative Care in Oncology he was granted a Diploma in Pain Management. Dr. Fadi recently conducted a study about adjuvant chemotherapy for high risk breast cancer in young women in UAE.</p> <p><strong>His core competencies are:&nbsp;</strong></p> <ul> <li>Medical Oncology and Hematology</li> <li>Breast cancer</li> <li>Colon Cancer</li> <li>Stomach cancer</li> <li>Brain tumors</li> <li>Head and Neck cancers</li> <li>Kidney cancer</li> <li>Testicular cancer</li> <li>Bladder cancer</li> <li>Gynecology cancers</li> <li>Prostate cancer</li> <li>Soft tissue cancers</li> <li>Bone cancers</li> <li>Blood and Lymphatic system cancers</li> <li>Skin cancers</li> </ul> Read More

<script type="application/ld+json"> {"@context":"https://schema.org/", "@type":"Physician", "name":"Benjamin Movsas", "url":"https://myacare.com/doctor/dr-benjamin-movsas-united-states", "description":"Dr. Movsas is a leading national expert in radiation oncology, stereotactic radiation, lung cancer and prostate cancer", "medicalSpecialty":["Radiation Oncologist","Stereotactic radiation Specialist","Lung Cancer Specialist","Prostate Cancer Specialist"], "memberOf":[{ "@type":"MedicalClinic","name":"Henry Ford Hospital", "url":"https://myacare.com/healthcare-provider/henry-ford-hospital-united-states" }] },] </script> <style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p><strong>Biographical Statement:</strong></p> <p>Dr. Movsas is a leading national expert in radiation oncology, stereotactic radiation, lung cancer, prostate cancer, and quality of life issues pertaining to cancer. Under his leadership, his department has the first FDA-approved combined MRI and linear accelerator unit (ViewRay MRLinac) in the world which allows for real time MRI tracking of tumors. Moreover, his department had the first Varian Edge dedicated stereotactic radiation unit in North America and has trained &gt;200 radiation doctors and physicists from all over the globe.</p> <p>Dr. Movsas has published extensively (with over 250 articles) on the topic of radiation therapy for cancer in many prestigious medical journals and regularly presents his research findings at some of the nation&rsquo;s top medical meetings. He is very passionate about improving the quality of life for his patients and he serves as the co-Chair of the National Cancer Institute (NCI) Patient Centered Outcomes Committee (PCOR) of the NRG cooperative group.</p> <p>Ranked as one of American&rsquo;s top cancer doctors, Dr. Movsas has been featured in Consumer&rsquo;s Guide to Top Doctors, HOUR Detroit&rsquo;s Top Docs, and the Castle Connolly&rsquo;s America&rsquo;s Top Doctors for Cancer.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr Hans van der Voet is a senior consultant clinical oncologist and radiotherapy lead at the James Cook University Hospital in Middlesbrough. He qualified at the University of Amsterdam Medical School in 1989 and started his radiotherapy training at The Netherlands Cancer Institute/Anthony van Leeuwenhoek Hospital in Amsterdam in 1990. He took a year out from training to do a clinical fellowship in bladder cancer at the Christie Hospital in Manchester from 1993. After completion of specialist training at the NCI/AvL in 1995, he returned to the Christie hospital as a senior registrar. In 1997 he took up a position as consultant clinical oncologist in Middlesbrough.</p> <p>Dr Hans van der Voet specialises and manages a busy practice in urological cancers, lower gastrointestinal cancer including anal cancer and sarcoma. He was instrumental in establishing image guided radiotherapy and subsequently intensity modulated radiotherapy in Middlesbrough. He has a vast experience in the treatment of prostate cancer including stereotactic radiotherapy.</p> <p>Dr Hans van der Voet also has an interest in providing radiotherapy for the treatment of early Dupuytren&rsquo;s disease and has been treating patients for this condition since 2013. Dr van der Voet is a member of the Northern Cancer Alliance Radiotherapy Expert Advisory Group.</p> Read More

<script type="application/ld+json"> {"@context":"https://schema.org/", "@type":"Physician", "name":"Santhi Nadarajan", "url":"https://myacare.com/doctor/dr-santhi-nadarajan-malaysia", "description":"Dr. Santhi Nadarajan graduated from the Manipal Medical College. She has a vast experience in the treatment of breast, lung, colorectal, gynecological, brain tumors, germ cell tumors, head & neck and gentourinary cancers.", "medicalSpecialty":["Oncologist","Consultant Clinical Oncologist"], "memberOf":[{ "@type":"MedicalClinic","name":"Gleneagles Hospital Kuala Lumpur", "url":"https://myacare.com/healthcare-provider/gleneagles-hospital-kuala-lumpur-malaysia" }] },] </script> <style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Santhi Nadarajan graduated from the Manipal Medical College and completed her Master of Clinical Oncology Degree from the University of Malaya. She has a vast experience in the treatment of breast, lung, colorectal, gynecological, brain tumors, germ cell tumors, head &amp; neck and gentourinary cancers. She has previously worked as a Consultant Clinical Oncologist at Radiotherapy and Oncology department, Hospital Kuala Lumpur.&nbsp;</p> <p>She also performs advanced radiotherapy techniques (i.e. IMRT) and systemic chemotherapy treatment. She also has undergone Stereotactic Radiosurgery and Therapy Training and has been actively involved in clinical research and presentation in her area of expertise.</p> <p>Dr. Santhi was awarded &quot;Excellent Service Award&quot; in 2019 by Johor Ministry of Health.</p> Read More

<style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. Rana Irfan Mahmood is a British trained oncologist with more than 20 years of clinical experience. He moved to Dubai from the NHS, UK where he was working as Consultant Oncologist, leading cancer services across Colchester and Ipswich hospitals as Clinical Director. He also worked in King Faisal Specialist Hospital &amp; Research Centre Riyadh as consultant oncologist while setting up advanced brachytherapy and Intra-operative radiotherapy services there in addition to enhancing the quality of cancer care as Quality Medical Director. He is well known for developing advanced forms of Image Guided Radiotherapy and Brachytherapy in several centres. Moreover, he is expert in managing patients with Immunotherapy for several types of cancers. Dr. Rana Mahmood has extensively published his clinical experience and research work in peer reviewed journals. He has trained a number of oncologists and teaches at the Royal College courses. He has been awarded Fellowship of both Royal College of Physicians and Royal College of Radiologists in UK. He led several international trials, for advanced radiotherapy, Immunotherapy and other biological/molecular agents. He is member of American Society of Oncology and European Society of Therapeutic Radiation Oncology.</p> <p>His special expertise include Stereotactic Radiotherapy (SABR/SBRT), MRI guided High Dose Rate (HDR) Brachytherapy for Cervix/Prostate cancer, LDR Brachytherapy for Prostate cancer, molecular radiotherapy, Biological targeted therapies and Immunotherapy.</p> Read More

<script type="application/ld+json"> {"@context":"https://schema.org/", "@type":"Physician", "name":"James O Peabody", "url":"https://myacare.com/doctor/dr-james-o-peabody-united-states", "description":"Dr. James O Peabody is a specialist in Urologic Oncology and robotic-assisted laparoscopic prostatectomy.", "medicalSpecialty":["Cancer Specialist","Urological Cancer Specialist","Oncologist","Specialist in robotic-assisted laparoscopic prostatectomy"], "memberOf":[{ "@type":"MedicalClinic","name":"Henry Ford Hospital", "url":"https://myacare.com/healthcare-provider/henry-ford-hospital-united-states" }] },] </script> <style type="text/css">body p { margin-bottom: 10px; text-align: Justify; } .about_the_doctor ul{ padding-left: 40px; margin-bottom: 10px; } </style> <p>Dr. James O. Peabody is a senior staff member of the Vattikuti Urology Institute (VUI) at Henry Ford Health System in Detroit, Mich.</p> <p>His specialties include urologic oncology and robotic-assisted laparoscopic prostatectomy. He worked with Mani Menon, M.D., and the team from the VUI on the development of the Institute&rsquo;s robotic surgery program. He has an interest in the teaching of robotic surgical techniques and serves as director of the Urology Residency Program at the VUI. In 1997, he was awarded the Joseph C. Cerny, M.D., Resident Teaching Award.</p> <p>Dr. Peabody received his medical degree from the University of Michigan Medical School in 1985. He did his postdoctoral training in General Surgery and Urology at Henry Ford Hospital, finishing in 1990.</p> <p>Dr. Peabody has authored 8 book chapters and more than 20 journal articles, and has more than 30 abstracts published.</p> Read More